All Curated Mutation Sites in EBOV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBOV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Keyword: Hemorrhagic fever, ebola-38278475

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	38278475	P429H	GP	GP	Hemorrhagic fever, ebola	G R	View
2	38278475	P429S	GP	GP	Hemorrhagic fever, ebola	G R	View
3	38278475	P429L	GP	GP	Hemorrhagic fever, ebola	G R	View
4	38278475	P429A	GP	GP	Hemorrhagic fever, ebola	G R	View
5	38278475	P429T	GP	GP	Hemorrhagic fever, ebola	G R	View
6	38278475	E305S	GP	GP	Hemorrhagic fever, ebola	G R	View
7	38278475	L306C	GP	GP	Hemorrhagic fever, ebola	G R	View
8	38278475	P430L	GP	GP	Hemorrhagic fever, ebola	G R	View
9	38278475	P430S	GP	GP	Hemorrhagic fever, ebola	G R	View
10	38278475	F443S	GP	GP	Hemorrhagic fever, ebola	G R	View
11	38278475	F443A	GP	GP	Hemorrhagic fever, ebola	G R	View
12	38278475	F443L	GP	GP	Hemorrhagic fever, ebola	G R	View
13	38278475	L444P	GP	GP	Hemorrhagic fever, ebola	G R	View
14	38278475	S307L	GP	GP	Hemorrhagic fever, ebola	G R	View
15	38278475	G122S	L	L	Hemorrhagic fever, ebola	G R	View
16	38278475	G122D	L	L	Hemorrhagic fever, ebola	G R	View
17	38278475	T233N	L	L	Hemorrhagic fever, ebola	G R	View
18	38278475	T233S	L	L	Hemorrhagic fever, ebola	G R	View
19	38278475	E539G	L	L	Hemorrhagic fever, ebola	G R	View
20	38278475	E539K	L	L	Hemorrhagic fever, ebola	G R	View
21	38278475	D767N	L	L	Hemorrhagic fever, ebola	G R	View
22	38278475	R1405Q	L	L	Hemorrhagic fever, ebola	G R	View
23	38278475	V1562I	L	L	Hemorrhagic fever, ebola	G R	View
24	38278475	V1597A	L	L	Hemorrhagic fever, ebola	G R	View
25	38278475	F1610C	L	L	Hemorrhagic fever, ebola	G R	View
26	38278475	F1610L	L	L	Hemorrhagic fever, ebola	G R	View
27	38278475	Q1716P	L	L	Hemorrhagic fever, ebola	G R	View
28	38278475	Q1716R	L	L	Hemorrhagic fever, ebola	G R	View
29	38278475	N1739S	L	L	Hemorrhagic fever, ebola	G R	View
30	38278475	T1772I	L	L	Hemorrhagic fever, ebola	G R	View
31	38278475	T1772A	L	L	Hemorrhagic fever, ebola	G R	View
32	38278475	Q1793R	L	L	Hemorrhagic fever, ebola	G R	View
33	38278475	I1951V	L	L	Hemorrhagic fever, ebola	G R	View
34	38278475	I2137F	L	L	Hemorrhagic fever, ebola	G R	View
35	38278475	K163Q	VP24	VP24	Hemorrhagic fever, ebola	G R	View
36	38278475	K163E	VP24	VP24	Hemorrhagic fever, ebola	G R	View
37	38278475	K163R	VP24	VP24	Hemorrhagic fever, ebola	G R	View
38	38278475	E224L	VP24	VP24	Hemorrhagic fever, ebola	G R	View
39	38278475	R635K	NP	NP	Hemorrhagic fever, ebola	G R	View

Contents
Description

The table shows all curated mutation sites of EBOV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.